TABRADOL (CYCLOBENZAPRINE HYDROCHLORIDE) KIT [CALIFORNIA PHARMACEUTICALS, LLC]

TABRADOL (CYCLOBENZAPRINE HYDROCHLORIDE) KIT [CALIFORNIA PHARMACEUTICALS, LLC]
PDF | XML

NDC 70332-106-01
Set ID 273003a5-23a9-21e4-e054-00144ff88e88
Category HUMAN PRESCRIPTION DRUG LABEL
Packager California Pharmaceuticals, LLC
Generic Name
Product Class
Product Number
Application Number
  • Tabradol - Pharmacist Instructions page 2

    Tabradol pharmacist instructions page 2

  • Tabradol - Label

    Tabradol Cyclobenzaprine label

  • Tabradol - Inactive ingredient - flavor label

    Tabradol flavor label

  • Tabradol - Pharmacist instructions Page 1

    Tabradol - pharmacist instructions page 1

  • Tabradol - Principal Label

    Tabradol Principal label

  • INGREDIENTS AND APPEARANCE
    TABRADOL 
    cyclobenzaprine hydrochloride kit
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:70332-106
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:70332-106-011 in 1 KIT
    Quantity of Parts
    Part #Package QuantityTotal Product Quantity
    Part 11 BOTTLE, PLASTIC 125 mL
    Part 21 BOTTLE, GLASS 0.25 g
    Part 31 BOTTLE, PLASTIC 125 mL
    Part 1 of 3
    STRUCTURED SUSPENSION VEHICLE 
    suspension liquid
    Product Information
    Route of AdministrationORAL
    Inactive Ingredients
    Ingredient NameStrength
    SORBITOL (UNII: 506T60A25R)  
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
    POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
    SODIUM BENZOATE (UNII: OJ245FE5EU)  
    DIMETHYL SULFONE (UNII: 9H4PO4Z4FT)  
    SACCHARIN SODIUM (UNII: SB8ZUX40TY)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1125 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other01/01/2016
    Part 2 of 3
    CYCLOBENZAPRINE HYDROCHLORIDE 
    cyclobenzaprine hydrochloride powder, for suspension
    Product Information
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CYCLOBENZAPRINE HYDROCHLORIDE (UNII: 0VE05JYS2P) (CYCLOBENZAPRINE - UNII:69O5WQQ5TI) CYCLOBENZAPRINE HYDROCHLORIDE0.25 g  in 0.25 g
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    10.5 g in 1 BOTTLE, GLASS; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other01/01/2016
    Part 3 of 3
    STRUCTURED FLAVORING VEHICLE 
    flavor liquid
    Product Information
    Route of AdministrationORAL
    Inactive Ingredients
    Ingredient NameStrength
    GLYCERIN (UNII: PDC6A3C0OX)  
    CHERRY (UNII: BUC5I9595W)  
    CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
    SODIUM CITRATE (UNII: 1Q73Q2JULR)  
    SODIUM BENZOATE (UNII: OJ245FE5EU)  
    WATER (UNII: 059QF0KO0R)  
    POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
    XANTHAN GUM (UNII: TTV12P4NEE)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1125 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other01/01/2016
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other01/01/2016
    Labeler - California Pharmaceuticals, LLC (021420944)
    Establishment
    NameAddressID/FEIBusiness Operations
    California Pharmaceuticals, LLC021420944manufacture(70332-106) , repack(70332-106)

Related Drugs